Stage IIIB Breast Cancer Terminated Phase 1 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01071564RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryTreatment
NCT01149356RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerTreatment
NCT01238133Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTreatment